Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a “freeze all” strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg
Authors:
- 1 February 2017
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 107 (2) , 379-386.e4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspectiveReproductive BioMedicine Online, 2011
- Expression, Regulation, and Function of Progesterone Receptors in Bovine Cumulus Oocyte Complexes During In Vitro Maturation1Biology of Reproduction, 2011
- Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effectCurrent Medical Research and Opinion, 2008
- LH neither too high nor too lowGynecological Endocrinology, 2007
- In vitro canine oocyte nuclear maturation in homologous oviductal cell co-culture with hormone-supplemented mediaTheriogenology, 2006
- The human cumulus–oocyte complex gene-expression profileHuman Reproduction, 2006
- Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilizationFertility and Sterility, 2005
- Oral micronized progesteroneClinical Therapeutics, 1999
- Radioimmunoassay of plasma progesterone after oral administration of micronized progesteroneThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Absorption and metabolism of oral progesterone.BMJ, 1980